<?xml version="1.0" encoding="UTF-8"?>
<!-- -->
<!-- Dette er en testmelding med fiktive personer -->
<!-- -->
<Message xmlns="http://www.kith.no/xmlstds/rekvisisjon/2008-12-01" xmlns:kith="http://www.kith.no/xmlstds" xmlns:xsd="http://www.w3.org/2001/XMLSchema.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.kith.no/xmlstds/rekvisisjon/2008-12-01 Rekvisisjon-v1_5.xsd">
	<Type V="R" DN="Rekvisisjon"/>
	<MIGversion>v1.5 2008-12-01</MIGversion>
	<GenDate V="2018-02-06T08:54:01"/>
	<MsgId>3051206f-f893-42ac-af15-1b0f4cd4eeba</MsgId>
	<ServReq>
		<ServType V="N" DN="Ny"/>
		<IssueDate V="2018-02-06T08:51:11"/>
		<MsgDescr V="LAB" DN="Laboratoriemedisin"/>
		<Id>5978d786-0367-4090-bd51-d49121bf9164</Id>
		<RequestedPrioReport V="NORM" DN="Normal"/>
		<Patient>
			<Sex V="2" DN="Kvinne"/>
			<DateOfBirth V="1969-11-13"/>
			<Name>Danser, Line</Name>
			<OffId>13116900216</OffId>
			<TypeOffId V="FNR" DN="FÃ¸dselsnummer"/>
			<ResponsibleHcp>
				<Relation V="REK" DN="Rekvirent"/>
				<HCP>
					<HCProf>
						<Type V="LE" DN="Lege"/>
						<Name>Rita Lin</Name>
						<Id>91101</Id>
						<TypeId V="HER" DN="HER-id"/>
					</HCProf>
					<Address>
						<Type V="WP" DN="Arbeidsadresse"/>
						<TeleAddress V="tel:73202600"/>
					</Address>
				</HCP>
			</ResponsibleHcp>
			<Address>
				<Type V="H" DN="Bostedsadresse"/>
				<StreetAdr>Numedalsveien 52</StreetAdr>
				<PostalCode>3602</PostalCode>
				<City>Kongsberg</City>
			</Address>
		</Patient>
		<ServProvider>
			<HCP>
				<Inst>
					<Name>ST OLAVS HOSPITAL HF</Name>
					<Id>59</Id>
					<TypeId V="HER" DN="HER-id"/>
					<Dept>
						<Name>Medisinsk biokjemi</Name>
						<Id>94673</Id>
						<TypeId V="HER" DN="HER-id"/>
					</Dept>
				</Inst>
			</HCP>
		</ServProvider>
		<Requester>
			<HCP>
				<Inst>
					<Name>Kattskinnet legesenter</Name>
					<Id>91096</Id>
					<TypeId V="HER" DN="HER-id"/>
					<HCPerson>
						<Name>Rita Lin</Name>
						<Id>91101</Id>
						<TypeId V="HER" DN="HER-id"/>
					</HCPerson>
				</Inst>
			</HCP>
		</Requester>
<!-- Medisinsk biokjemi -->
		<ReqInvestigation>
			<ServType V="N" DN="Ny"/>
			<Investigation>
				<Id V="NPU03429" S="2.16.578.1.12.4.1.1.7280" DN="P-Natrium"/>
			</Investigation>
			<Investigation>
				<Id V="NPU03230" S="2.16.578.1.12.4.1.1.7280" DN="P-Kalium"/>
			</Investigation>
			<Investigation>
				<Id V="NOR05809" S="2.16.578.1.12.4.1.1.7280" DN="Us-Ferritin"/>
			</Investigation>
			<Investigation>
				<Id V="NPU18106" S="2.16.578.1.12.4.1.1.7280" DN="Us-Triglyserid"/>
			</Investigation>
			<Investigation>
				<Id V="NOR05865" S="2.16.578.1.12.4.1.1.7280" DN="Us-TSH"/>
			</Investigation>
			<Investigation>
				<Id V="NOR05863" S="2.16.578.1.12.4.1.1.7280" DN="Us-FT4"/>
			</Investigation>
			<Investigation>
				<Id V="NPU29868" S="2.16.578.1.12.4.1.1.7280" DN="P-Digoksin"/>
			</Investigation>
			<AnalysedSubject>
				<CollectedSample>
					<CollectedDate V="2018-02-06T08:52:15"/>
				</CollectedSample>
				<TypeCoded S="2.16.578.1.12.4.1.1.8351" V="S" DN="Serum"/>
				<IdByRequester>79209fb0-0b3a-11e8-b566-0800200c9a66</IdByRequester>
				<IdByServProv>f7737880-0b4c-11e8-b566-0800200c9a66</IdByServProv>
			</AnalysedSubject>
		</ReqInvestigation>
		<ReqInvestigation>
			<ServType V="N" DN="Ny"/>
			<Investigation>
				<Id V="NPU04073" S="2.16.578.1.12.4.1.1.7280" DN="P-Homocystein"/>
			</Investigation>
			<AnalysedSubject>
				<CollectedSample>
					<CollectedDate V="2018-02-06T08:52:15"/>
				</CollectedSample>
				<TypeCoded S="2.16.578.1.12.4.1.1.8351" V="P" DN="Plasma"/>
				<IdByRequester>79209fb0-0b3a-11e8-b566-0800200c9a66</IdByRequester>
				<IdByServProv>b8a333c0-0b51-11e8-b566-0800200c9a66</IdByServProv>
			</AnalysedSubject>
		</ReqInvestigation>
		<ReqInvestigation>
			<ServType V="N" DN="Ny"/>
			<Investigation>
				<Id V="NPU12537" S="2.16.578.1.12.4.1.1.7280" DN="P-Gliadin IgG"/>
			</Investigation>
			<Investigation>
				<Id V="NPU14566" S="2.16.578.1.12.4.1.1.7280" DN="P-Transglutaminase IgA"/>
			</Investigation>
			<AnalysedSubject>
				<CollectedSample>
					<CollectedDate V="2018-02-06T08:52:15"/>
				</CollectedSample>
				<TypeCoded S="2.16.578.1.12.4.1.1.8351" V="S" DN="Serum"/>
				<IdByRequester>79209fb0-0b3a-11e8-b566-0800200c9a66</IdByRequester>
				<IdByServProv>dbf946a0-4023-11e8-b566-0800200c9a66</IdByServProv>
			</AnalysedSubject>
		</ReqInvestigation>
<!-- Immunologi -->
		<ReqInvestigation>
			<ServType V="N" DN="Ny"/>
			<Investigation>
				<Id V="NPU03952" S="2.16.578.1.12.4.1.1.7280" DN="P-Kusmavirus (parotittvirus) IgG"/>
			</Investigation>
			<Investigation>
				<Id V="NPU03953" S="2.16.578.1.12.4.1.1.7280" DN="P-Kusmavirus (parotittvirus) IgM"/>
			</Investigation>
			<AnalysedSubject>
				<CollectedSample>
					<CollectedDate V="2018-02-06T08:52:15"/>
				</CollectedSample>
				<TypeCoded S="2.16.578.1.12.4.1.1.8351" V="S" DN="Serum"/>
				<IdByRequester>79209fb0-0b3a-11e8-b566-0800200c9a66</IdByRequester>
				<IdByServProv>cd4515d0-4023-11e8-b566-0800200c9a66</IdByServProv>
			</AnalysedSubject>
		</ReqInvestigation>
<!-- Medisinsk genetikk -->
		<ReqInvestigation>
			<ServType V="N" DN="Ny"/>
			<Investigation>
				<Id V="NPU19270" DN="DNA-F5(Leidenmutasjonen, Arg506Gln)" S="2.16.578.1.12.4.1.1.7280"/>
			</Investigation>
			<AnalysedSubject>
				<CollectedSample>
					<CollectedDate V="2017-01-10"/>
				</CollectedSample>
				<Type>Blod</Type>
				<IdByServProv>67796679</IdByServProv>
			</AnalysedSubject>
		</ReqInvestigation>
<!-- Klinisk farmakologi -->
		<ReqInvestigation>
			<ServType V="N" DN="Ny"/>
			<Investigation>
				<Id V="NPU22274" DN="P-Digoksin" S="2.16.578.1.12.4.1.1.7280"/>
			</Investigation>
			<AnalysedSubject>
				<CollectedSample>
					<CollectedDate V="2017-01-10"/>
				</CollectedSample>
				<Type>Urin</Type>
				<IdByServProv>65596674</IdByServProv>
			</AnalysedSubject>
		</ReqInvestigation>
	</ServReq>
</Message>
